comparemela.com

கஸ்க் ல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GSK to seek regulatory approval for Covid-19 antibody following positive clinical trial study | 11 March 2021

FTSE 100 slightly higher on US stimulus boost | 11 March 2021

11 March 2021 | 09:52am StockMarketWire.com - The FTSE 100 was up more than 27 points at 6,752.17, as investors cheered news that the US Congress backed the $1.9 trillion stimulus plan. Morrisons has seen pre-tax profits fall more than 60% in 2020, with a £290 million hit relating to Covid costs , despite a rise in sales and revenue for the high street supermarket chain. Its shares dipped 0.5% to 176.2p. Rolls Royce has said its performance in 2020 has been significantly affected by the COVID-19 pandemic as it reported a fall in revenue to £11.8 billion. It advanced 2.1% to 115.4p. WPP has said it had a remarkably resilient 2020 as it reported a 9.3% fall in revenue to £12 billion. It advanced 0.9% to 920.6p.

GlaxoSmithKline and Vir Biotechnology to expand antibody collaboration | 17 February 2021

GSK s ViiV Healthcare gets regulatory nod for HIV treatment in US | 22 January 2021

UK markets head lower; Computacenter climbs | 22 January 2021

22 January 2021 | 08:35am StockMarketWire.com - News that UK borrowing hit £34.1 billion in December 2020, the third-highest borrowing in any month since monthly records began in 1993, weighed heavily on UK markets, which opened lower. Meanwhile, the latest figures showed mixed retail sales figures, with a 0.3% increase in retail sales volumes in December when compared with the previous month, helped by a rebound in sales at clothing stores, but a record annual decline in sales volumes of 25% for clothing stores in 2020 when compared with 2019. The FTSE 100 was down 0.3%, or 17.99 points, to 6,697.43, while the FTSE 250 was also 0.3% lower to 20,740.21. Pharmaceutical giant GlaxoSmithKline was buoyed 0.2% to £13.66 on the announcement that ViiV Healthcare, which it majority owns, has received US regulatory approval for its HIV treatment regime Cabenuva.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.